301060 兰卫医学
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.041-6.365-7.36834.02914.627
总资产报酬率 ROA (%)-0.026-3.901-4.20521.09711.397
投入资产回报率 ROIC (%)-0.035-5.288-6.18830.49014.152

边际利润分析
销售毛利率 (%)24.18822.08220.80142.63638.232
营业利润率 (%)2.266-3.978-8.11222.60617.935
息税前利润/营业总收入 (%)2.145-5.570-8.94621.72017.943
净利润/营业总收入 (%)0.926-5.659-9.65817.59914.711

收益指标分析
经营活动净收益/利润总额(%)169.360-7.9257.078124.74599.158
价值变动净收益/利润总额(%)-3.339-4.2601.3830.2673.198
营业外收支净额/利润总额(%)-16.41832.59011.367-4.957-0.288

偿债能力分析
流动比率 (X)3.0793.2472.8272.3974.279
速动比率 (X)2.5442.7492.3812.1133.941
资产负债率 (%)31.28430.61033.70439.34322.117
带息债务/全部投入资本 (%)10.88213.21716.07211.8621.360
股东权益/带息债务 (%)796.671635.982511.272721.9207,018.742
股东权益/负债合计 (%)207.483206.492176.847139.966336.060
利息保障倍数 (X)10.778-16.789-43.468119.390303.208

营运能力分析
应收账款周转天数 (天)185.417185.683347.656129.355132.613
存货周转天数 (天)101.15689.346104.41340.42246.960